TV
Travere Therapeutics, Inc.
TVTX · NASDAQ
$62.76 -3.28% (-$2.13)
1M -4.49%
Market Cap $6.02B
P/E Ratio -
Div. Yield -
ROE 55.79%
Piotroski F-Score Moderate
5/9Valuation
0 /100
Expensive EV/EBITDA 4,222.49x
P/S 10.18x
P/FCF 116.86x
Growth
100 /100
Growing Rev. growth 64.89%
Book val. growth 38.90%
EPS growth N/A
Profitability
38 /100
Moderate Gross margin 94.41%
Net margin 7.35%
FCF margin 8.71%
Quality
9 /100
Poor ROIC 6.25%
ROE 55.79%
Asset turnover 0.74x
Debt
15 /100
High Debt/Equity 25.16x
Current ratio 4.05x
Net debt/EBITDA 323.30x
Stability
23 /100
Unstable Beta 1.06x
Rev. volatility 39.40%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TVTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Eric Dube
Employees
497
Headquarters
San Diego
Evenimente viitoare
29 OCT.
Earnings
Upcoming earnings report